BuyDomains owns and operates a very large domain name portfolio consisting of hundreds of thousands of domain names – possibly millions. Many of the domain names I have seen are inventory quality domain names that would be desired by small to medium-sized businesses. I would guess the company sells a greater volume of domain names that just about any other industry company focusing on end user sales.
For many years, BuyDomains has publicly shared a percentage of its domain name sales that aren’t subject to confidentiality agreements. Each year, the company has shared thousands of domain names, and those sales were syndicated by NameBio. In 2022 alone, BuyDomains reported 4,261 domain name sales worth nearly $10 million USD, according to NameBio. In the past 5 years, the company has reported $43.8 million in domain name sales.
Over the weekend, Alexej Kirillov asked NameBio if BuyDomains stopped reporting its domain name sales publicly:
@NameBio Holla, did BuyDomains stop reporting sales? Last update was on 12th Sept, almost impossible for them not to have any sales since?
— Alex (@AlexejKirillov) September 16, 2023
Michael Sumner, CEO of NameBio, confirmed that BuyDomains stopped publishing its sales on its homepage, and consequently its sales are no longer being shared:
They stopped publishing them on their homepage, which is where we got them from. I have a request in to get a feed, and a proposal is working it’s way through upper management, but we’ll see. Huge loss for the industry if they stop sharing 😔
— NameBio (@NameBio) September 16, 2023
BuyDomains sells a high quantity of desirable domain names, and its sales data is invaluable to the market at-large. The data is not only helpful to domain investors who can see what types of domain names are selling at what prices, but it is also valuable to prospective buyers who are seeking to justify the purchase of other domain names.
Hopefully BuyDomains opts to provide a sales feed to NameBio.